Human T-cell lymphotrophic virus infection in organ donors: A need to reassess policy?

American Journal of Transplantation

Volumn 2, Issue 7, 2002, Pages 658-663

  Shames, Brian D ^a   D'Alessandro, Anthony M ^a   Sollinger, Hans W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

HTLV

Indexed keywords

ARTICLE; HEALTH CARE POLICY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; ORGAN DONOR; PREVALENCE; RISK ASSESSMENT; SCREENING; VIRUS TRANSMISSION;

ADULT; AGED; DELTARETROVIRUS INFECTIONS; HEALTH POLICY; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMANS; MIDDLE AGED; ORGAN TRANSPLANTATION; RISK FACTORS; TISSUE DONORS; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES;

EID: 0036705549     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20712.x     Document Type: Article

References (43)

1. Poiesz BJ, Ruscetti FW, Reitz MS, Kalyanaraman VS, Gallo RC. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukemia. Nature 1981; 294: 268-271.
2. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I. Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy-cell leukemia. Science 1982; 218: 571-573.
3. Popovic M, Reitz MS, Sarngadharan MG et al. The virus of Japanese adult T-cell leukemia is a member of the human T-cell leukemia virus group. Nature 1982; 300: 63-66.
4. Osame M, Usuku K, Izumo S et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; i: 1031-1032.
5. Tokudome S, Tokunaga O. Shimamoto Y et al. Incidence of adult T-cell leukemia/lymphoma among human T-lymphotrophic virus type I carriers in Saga, Japan. Cancer Res 1989; 49: 226-228.
6. Kondo T, Kono H, Miyamoto N et al. Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer 1989; 43: 1061-1064.
7. Murphy EL, Hanchard B, Figueroa JP et al. Modeling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotrophic virus type I. Int J Cancer 1989; 43: 250-253.
8. Cleghorn FR, Manns A, Falk Ret al. Effect of human T-lymphotrophic virus type I infection on non-Hodgkin's lymphoma incidence. J Natl Cancer Inst 1995; 87: 1009-1014.
9. Maloney EM, Cleghorn FR, Morgan OSC et al. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr 1997; 17: 167-170.
10. Manns A, Hisada M, Grenada LL. Human T-lymphotrophic virus type I infection. Lancet 1999; 353: 1951-1958.
11. Goedert JJ, Fung MW, Felton S, Battjes RJ, Engels EA. Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA. AIDS 2001; 15: 1295-1302.
12. Hollsberg P, Hafler DA. Pathogenesis of diseases induced by human lymphotrophic virus type I infection. N Engl J Med 1993; 328: 1173-1182.
13. Glynn SA, Kleinman SH, Schreiber GB et al. Trends in the incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991-96. JAMA 2000; 284: 229-235.
14. Levine PH, Dosik H, Joseph EM et al. A study of adult T-cell leukemia/lymphoma incidence in central Brooklyn. Int J Cancer 1999; 80: 662-666.
15. Harrington WJ, Ucar A, Gill P et al. Clinical spectrum of HTLV-I in south Florida. J Acquir Immune Defic Syndr 1995; 8: 466-473.
16. Dosik H, Goldstein MF, Poiesz BJ et al. Seroprevalence of human T-lymphotrophic virus in black from a selected central Brooklyn population. Cancer Invest 1994; 12: 289-295.
17. Murphy EL, Watanabe K, Nass CC et al. Evidence among blood donors for a 30-year-old epidemic of human T lymphotrophic virus type II infection in the United States. J Infect Dis 1999; 180: 1777-1783.
18. Perez G, Ortiz-Interian C, Lee H et al. Human immunodeficiency virus and human T-cell leukemia virus type I in patients undergoing maintenance hemodialysis in Miami. Am J Kidney Dis 1989; 14: 39-43.
19. Kleinman SH, Swanson P, Allain JP, Lee H. Transfusion transmission of human T-lymphotrophic virus types I and II. serologic and polymerase chain reaction results in recipients identified through look-back investigations. Transfusion 1993; 31: 14-18.
20. Sullivan MT, Williams AE, Fang CT, Grandinetti T, Poiesz BJ, Ehrlich GD. Transmission of human T-lymphotrophic virus types I and II by blood transfusion. Arch Intern Med 1991; 151: 2043-2048.
21. Donegan E, Lee H, Operskalski EA et al. Transfusion transmission of retroviruses: human T-lymphotrophic virus types I and II compared with human immunodeficiency virus type I. Transfusion 1994; 34: 478-483.
22. Remesar MC, Pozo AE, Pittis MG, Mangano AM, Sen L, Briones L. Transmission of HTLV-I by kidney transplant. Transfusion 2000; 40: 1421-1422.
23. Zaaijer H. Human T-lymphotrophic virus infection: Is it a threat? Transplant Proc 1996; 28: 2940.
24. Gridelli B, Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med 2000; 343: 404-410.
25. Claquin J, Romano P, Noury D et al. Human T-lymphotrophic virus 1-2 antibodies in potential organ donors in France. Transplant Proc 1996; 28: 189-190.
26. Claquin J, Romano P, Sellami F, Gassin M. Human T cell lymphotrophic virus 1-2-positive nonretrieved cerebral deaths in France. 1992-94. Transplant Proc 1996; 28: 2953.
27. Mate G, Gonzalez C, Bronsoms JM, Valles M, Torguet P, Mauri JM. Transplant and organ donor-associated transmission of human T-lymphotrophic virus types I and II. Transplant Proc 1995; 27: 2417.
28. Domen RE, Nelson KA. Results of a survey of infectious disease testing practices by organ procurement organizations in the United States. Transplantation 1997; 63: 1790-1794.
29. Zanke BW, Rush DN, Jeffery JR, Israel LG. HTLV-I T-cell lymphoma in cyclosporine-treated renal transplant patients. Transplantation 1989; 48: 695-697.
30. Tsurumi H, Tani K, Tsuruta T, Shirato R, Matsudaira T, Tojo A et al. Adult T-cell leukemia developing during immunosuppressive treatment in a renal transplant recipient. Am J Hematol 1992; 41: 292-294.
31. Williams NP, Buchner LM, Shah DJ, Williams W. Adult T-cell leukemia/lymphoma in a renal transplant recipient: An opportunistic occurrence. Am J Nephrol 1994; 14: 226-229.
32. Jenks PJ, Winsome BY, Raftery MJ et al. Development of human T-cell lymphotrophic virus type I-associated adult T-cell leukemia/lymphoma during immunosuppressive treatment following renal transplantation. Clin Infect Dis 1995; 21: 992-993.
33. Hoshida Y, Li T, Dong Z et al. Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer 2001; 91: 869-875.
34. Nakamura N, Arakaki Y, Sunagawa AH et al. Influence of immunosuppression in HTLV-1 - positive renal transplant recipients. Transplant Proc 1998; 30: 1324-1326.
35. Tanabe K, Kitani R, Takahashi K et al. Long-term results in human T-cell leukemia virus type 1-positive renal transplant recipients. Transplant Proc 1998; 30: 3168-3170.
36. Natazuka T, Umemiya-Okada T, Matsui T, Saida T, Nakao Y. FK506 and cyclosporine a regulate proliferation and proto-oncogene expression in HTLV-I-associated myelopathy/tropical-spastic-paraparesis-derived T cells. Int J Cancer 1993; 54: 348-354.
37. Andrada-Serpa MJ, Schor D, Araujo AQ, Rumjanek VM. Immunological features of HTLV-I myelopathy in Rio de Janeiro, Brazil, and in vitro effects of cyclosporine A. J Neurol Sci 1996; 139: 7-14.
38. Kuroda Y, Takashima H, Yukitake M, Sakemi T. Development of HTLV-I-associated myelopathy after blood transfusion in a patient with aplastic anemia and a recipient of a renal transplant. J Neurol Sci 1992; 109: 196-199.
39. Nakatsuji Y, Sugai F, Watanabe S et al. HTLV-I-associated myelopathy manifested after renal transplantation. J Neurol Sci 2000; 177: 154-156.
40. Gout O, Baulac M, Gessain A et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990; 322: 383-388.
41. Fretz C, Jaulmes D, Jordan G, Fournal JJ. HTLV-I transmission and myelopathy induced by blood transfusion. Transfusion 1991; 31: 379.
42. Panico M, Solomon M, Burrows L. Issues of informed consent and access to extended donor pool kidneys. Transplant Proc 1997; 29: 3667-3668.
43. Sells RA. Informed consent from recipients of marginal organ donors. Transplant Proc 1999; 31: 1324-1325.